White Coat Hypertension in Definition of Metabolic Syndrome

Basit Öğe Kaydı
dc.contributor.authorHelvaci, Mehmet Rami
dc.contributor.authorKaya, Hasan
dc.contributor.authorSeyhanli, Mahmut
dc.contributor.authorYalcin, Atilla
dc.date.accessioned2024-09-18T21:00:43Z
dc.date.available2024-09-18T21:00:43Z
dc.date.issued2008
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractAlthough white coat hypertension (WCH) is believed to have,in effect on health, there is no term defining WCH in metabolic syndrome. Consecutive patients 20 years old or older Who Underwent a check-up were included. The study included 1068 cases. The prevalences of hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, impaired glucose tolerance (IGT), and WCH were similar to excess weight in that they increased significantly until the seventh decade of life and decreased thereafter significantly (P < 0.05 in most steps'). On the other hand, the prevalences of hypertension (I-IT), diabetes mellitus (DM), and coronary heart disease (CHD) always increased significantly with age without any decrease (P < 0.05 in most steps), indicating their irreversibility in contrast to the reversibility of excess weight, hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, IGT, and WCH. Metabolic syndrome is a reversible progression step between health and irreversible final diseases terminating with increased mortality and disabilities. Thus, the definition of metabolic syndrome should include reversible metabolic risk factors such as excess weight (overweight and obesity), hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, IGT. and WCH, instead of irrevesible diseases such as DM, I-IT, Cl-ID, and stroke that have already developed and require drug therapy. After development of one of the final metabolic diseases, the term metabolic syndrome probably loses most of its significance, since from that point on, nonpharmacetical approaches Such as lifestyle changes, diet, and exercise will provide little benefit to prevent development of the others, most likely due to the cumulative effects of the risk factors on body systems over a long period of time. (Int Heart J 2008; 49: 449-457)en_US
dc.identifier.doi10.1536/ihj.49.449
dc.identifier.endpage457en_US
dc.identifier.issn1349-2365
dc.identifier.issn1349-3299
dc.identifier.issue4en_US
dc.identifier.pmid18753728en_US
dc.identifier.scopus2-s2.0-52149103342en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage449en_US
dc.identifier.urihttps://doi.org/10.1536/ihj.49.449
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12835
dc.identifier.volume49en_US
dc.identifier.wosWOS:000260124600007en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherInt Heart Journal Assocen_US
dc.relation.ispartofInternational Heart Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectWhite coat hypertensionen_US
dc.subjectMetabolic syndromeen_US
dc.subjectExcess weighten_US
dc.subjectDyslipidemiaen_US
dc.subjectImpaired glucose toleranceen_US
dc.titleWhite Coat Hypertension in Definition of Metabolic Syndromeen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
145.51 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu